IngredientsArbutus menziesii, or Pacific madrone (commonly madrone or madrona in the United States and arbutus in Canada), is a species of broadleaf evergreen tree in the family Ericaceae. Pacific madrone is the largest flowering tree of the family Ericaceae. Its full botanical authority is Arbutus menziesii Pursh, having been formally described by the botanist Frederick Pursh. The scientific name honors the discoverer, Archibald Menzies (1754ā1842), a Scottish physician and naturalist. The common name, Madrone, is derived from the Spanish word madroƱo (which also means "strawberry tree") and was named by Father Juan Crespi, who was a chronicler of the overland Portola expedition of 1769 to discover the "lost bay" of Monterey.
Common names in widespread use include:
There are about 14 species in the genus Arbutus globally. Arbutus species occur in Western Europe, the Mediterranean, and North America. Arbutus menziesii is the sole representative of the genus native to the Pacific Coast of North America. Its closest relative in medicinal and phytochemical research is Arbutus unedo L. (the Mediterranean strawberry tree), which has been far more extensively studied scientifically; phytochemical data from A. unedo are referenced in the sections below where they are the best available proxy for the genus, and are clearly distinguished from A. menziesii-specific findings.
Arbutus menziesii has waxy foliage, a contorted growth habit, and flaky bark. It is native to the western coastal areas of North America, from British Columbia to California. It is an evergreen tree about 10 to 25 metres (33 to 82 feet) in height, but in the right conditions up to 30 m (98 ft). The trunk is usually about 60 centimetres (24 inches) thick. The thin bark is a rich orange-red, and when mature naturally peels away in thin sheets, leaving a greenish, silvery appearance that has a smooth satin sheen. Individual trees can live for over 300 years.
Pacific madrone is a large, long-lived tree that naturally occurs in a climate with mild, wet winters and dry summers, although rainfall varies substantially within its range, from the east coast of Vancouver Island in British Columbia, southward through Washington and Oregon (west of the Cascades) to San Diego County.
The plant parts used medicinally and as dietary ingredients include:
The bark was often made into tea to be drunk for supposed medicinal purposes. Madrone berries are edible but can be astringent ā eaten fresh in small quantities, cooked, dried, or brewed into a cider-like beverage. Indigenous people have eaten the fruit fresh, roasted or dried, as well as using them for "cider," not necessarily fermented.
Various Native American peoples used bark infusions medicinally, on cuts and against various digestive, respiratory and skin ailments; some of these uses were still current on Vancouver Island in the late 20th century (Turner & Hebda 1990).
Ethnobotanical studies, most notably the systematic interviews published by Turner and Hebda (1990) in the Journal of Ethnopharmacology, documented medicinal bark use among Salishan peoples. Elders of the Saanich and Cowichan Coast Salish people of southern Vancouver Island treat, or have treated in the recent past, many ailments with bark preparations. Interviews with two elder Salishan women revealed that respiratory ailments were treated with bark of Arbutus menziesii (among other species); digestive tract ailments with bark of Arbutus menziesii (among others); and gynaecological problems with bark of Arbutus menziesii (among others).
The Arbutus is important to the Straits Salish people of Vancouver Island, who used Arbutus bark and leaves to create medicines for colds, stomach problems, and tuberculosis, and as the basis for contraceptives.
Many Pacific Northwest tribes (including the Cowichan, Hoh, Saanich, Salish, and others) have used the leaves as a burn dressing. An infusion of bark has been used to treat cuts, wounds, and as a diabetes treatment. The leaves have been smoked. The leaves have been chewed and the juice swallowed to treat colds and sore throats. An infusion of leaves has been used to treat stomach ulcers and sore throats.
The WSANEÄ peoples used the bark and leaves medicinally to help treat colds, stomach aches, and cramps and as a post-childbirth contraceptive.
Pacific Madrone holds profound cultural significance for Indigenous peoples of the Pacific Coast, particularly among California, Oregon, and southern British Columbia tribes. The Yurok, Hupa, Karuk, Pomo, and other Northern California nations considered madrone berries a crucial staple food source, ranking among the most important wild foods in their seasonal diet. The bright red berries were eaten fresh during the harvest season, dried and stored for winter consumption, or ground into flour for making nutritious bread and cakes that could be stored for months.
The Mendocino and other California peoples used inner bark preparations in women's medicine, demonstrating the sophisticated pharmacological knowledge of Indigenous communities.
Communities along the Klamath River used the berries for bait when fishing for steelhead.
Multiple preparation forms have been recorded across different tribal traditions:
In spiritual practices, madrone was often considered a sacred tree, and many tribes maintained specific protocols for respectfully harvesting its bark, berries, and wood. The WĢ±SĆNEÄ people of British Columbia have a prohibition against burning arbutus due to its salvific role in their creation myths; an arbutus anchored their canoes to the world during the deluge.
Spanish colonizers named the tree "madroƱo" after a similar European species (Arbutus unedo), and European settlers quickly adopted Indigenous uses of the berries for food, making jellies, preserves, and fermented beverages.
The phytochemical profile of Arbutus menziesii specifically has received much less formal laboratory characterization than that of its Mediterranean congeners, particularly Arbutus unedo. The most directly relevant study of A. menziesii as a source of bioactive compounds is the 1963 work by Kabadi and Hammarlund, which identified the antibacterial constituent "madronin" from leaves. Broader characterization of the genus provides context for understanding the probable phytochemistry of A. menziesii.
The antibacterially active compound "madronin" from the leaves of Pacific Madrona tree has been tentatively identified as a mixture of gallotannin and catechol tannin in addition to varying amounts of their degradation products, gallic acid, m-digallic acid, possibly trigallic acid, catechol, phloroglucinol, and glucose. Experimental evidence includes results of qualitative physical and chemical analyses, light absorption, paper chromatography, and microbiological fermentation tests.
The leaves contain "one or more antibacterial substances which were active in vitro mainly against Gram-positive and acid-fast bacteria. Their studies indicated the presence of several substances having similar chemical and anti-bacterial activities and the name 'madronin' was given to the crude mixture of the active material."
Tannins are the dominant and best-documented class of bioactive compounds across the Arbutus genus. In A. menziesii, the bark and leaves contain high concentrations of condensed (catechol) tannins and hydrolyzable (gallotannin) tannins, as identified directly in the Kabadi and Hammarlund (1963) study. The fruit is edible, but due to its high tannin content, it is quite astringent.
In comparative studies across Arbutus species, A. menziesii (Am) exhibited the highest procyanidin concentration (6.48 Ā± 0.48 mg CE/g DW) among the species evaluated, following a consistent trend with the total phenolic and flavonoid contents. UPLCāESIāMS/MS analysis allowed for the identification of 38 phenolic compounds in Arbutus spp.
Arbutin (hydroquinone-Ī²-d-glucopyranoside) is a hallmark compound of the Ericaceae family and has been identified across multiple Arbutus species. Arbutin occurs in high levels in plants in the families Ericaceae and Saxifragaceae. In studies of Arbutus fruit phenolics by HPLC and NMR, arbutin was characterized along with beta-D-glucogalline, gallic acid 4-O-beta-D-glucopyranoside, 3-O-galloylquinic acid, 5-O-galloylquinic acid, 3-O-galloylshikimic acid, and 5-O-galloylshikimic acid.
The Arbutus genus is characterized by a diverse flavonoid profile. Studies across closely related species have identified catechin, epicatechin, catechin gallate, myricetin, rutin, quercetin, kaempferol, hyperoside (quercetin-3-O-galactoside), isoquercetin, and various flavonoid glycosides. Several components belonging to diverse phenol groups have been reported in Arbutus fruits: phenolic acids, flavonols, flavan-3-ols and galloyl derivatives, and anthocyanins.
The phenolic constituents of A. unedo fruits included anthocyanins (delphinidin-3-O-galactoside, cyanidin-3-O-glucose and cyanidin-3-O-arabinoside), 4-arbutin, Ī²-d-glucogalline, 3-O-galloylquinic acid, gallic acid-4-O-Ī²-d-glucopyranoside, 5-O-galloylquinic acid, 5-O-galloylshikimic acid, and 3-O-galloylshikimic acid, identified by HPLC-DAD-ESI-MS. These anthocyanins are responsible for the red pigmentation of berries across the genus.
In lipophilic analyses of Arbutus fruit and plant material, forty-one compounds were identified and among these, ursolic acid, lupeol, Ī±-amyrin, linoleic and Ī±-linolenic acids, and Ī²-sitosterol were highlighted as the major components in A. unedo berries. These triterpenoid compounds are characteristic of the wider Ericaceae family and are likely present across the genus, though direct speciation data for A. menziesii specifically are limited in the published literature.
The plant has been shown to contain different phytoconstituents such as flavonoids, tannins, phenolic acids, organic acids, Ī±-tocopherol, carotenoids, anthocyanins, triterpenoids, fatty acids, sterols, vitamin C, fibers, calcium (Ca), potassium (K), magnesium (Mg), phosphorus (P), and other bioactive compounds, which contribute to its various pharmacological and nutritional properties.
Proposed biological mechanisms are derived primarily from studies of the identified constituent classes (tannins, arbutin, flavonoids, polyphenols) or from studies of closely related species in the genus. No controlled human pharmacological mechanism studies have been published specifically for A. menziesii preparations.
The high tannin content of bark and leaves is the principal basis for the astringent and wound-healing properties attributed to Pacific madrone in traditional use. Since tannin has been shown to be a rather potent antibacterial substance for many microorganisms, its possible influence upon the various surveys for antibacterial agents is well documented. Gallotannins and catechol tannins act by precipitating proteins, disrupting bacterial cell membranes, and binding to microbial enzymes.
Multiple in vitro methods demonstrate radical-scavenging and antioxidant activity in Arbutus extracts, attributable primarily to polyphenols. The antioxidant properties of the leaves of the Mediterranean strawberry tree (Arbutus unedo L.) are mainly attributed to the main bioactive compound, the phenolic glycoside arbutin. Tannins, flavonoids, and anthocyanins also contribute to antioxidant capacity through electron-donation and radical-chain termination mechanisms.
Arbutin acts as an enzyme inhibitor of cellular tyrosinase by inactivating it. Tyrosinase is an enzyme needed in melanin synthesis in the melanin-producing cell of the skin, the melanocyte. By reducing the activity of tyrosinase, Ī²-arbutin reduces the synthesis of melanin, leading to a lighter skin tone and the diminished appearance of hyperpigmentation.
Arbutin has a long history of use in urinary phytotherapy. For centuries, Ī²-arbutin has been used in phytotherapy, or herbal medicine. Extracted from the leaves of bearberry plants, it is used as a mixture with other herbal drugs as a treatment for urinary tract infections. In the urinary tract, hydrolysis of arbutin releases free hydroquinone, which has antiseptic properties in an alkaline urine environment.
Studies on related Arbutus species show polyphenol-rich extracts inhibit pro-inflammatory mediators, including lipoxygenase, in vitro. In vitro assays showed that A. unedo essential oil significantly inhibits (ICā ā = 86.14 Ā± 0.05 Ī¼g/mL) 5-lipoxygenase. These effects are principally attributed to the polyphenolic fraction. No equivalent study has been published for A. menziesii extracts specifically.
Critical note on evidence quality: As of the current literature, there are no published human clinical trials specifically evaluating Arbutus menziesii bark, leaf, or berry preparations as dietary supplements. The scientific evidence base consists of: (a) one direct in vitro study identifying the antibacterial principle "madronin" from A. menziesii leaves (Kabadi & Hammarlund, 1963); (b) ethnobotanical documentation; and (c) in vitro and some in vivo animal data from the closely related species A. unedo, A. andrachne, A. arizonica, and A. pavarii. This section accurately characterizes the evidence base for each area.
Direct A. menziesii evidence (in vitro, 1963): The foundational study by Kabadi and Hammarlund (J. Pharm. Sci., 1963) identified "madronin" from the leaves of Pacific Madrona as a mixture of gallotannin and catechol tannin and their degradation products, with activity demonstrated against Gram-positive and acid-fast bacteria. Experimental evidence includes results of qualitative physical and chemical analyses, light absorption, paper chromatography, and microbiological fermentation tests.
This constitutes preliminary, single-era in vitro evidence only. No subsequent human clinical studies or even modern in vitro studies with standardized extracts of A. menziesii have been published in the indexed literature. Evidence from related species: Strawberry tree leaves exhibited antibacterial activity against Staphylococcus aureus, but there was no inhibitory effect against Escherichia coli and Salmonella enteritidis.
Evidence strength: Very preliminary (single in vitro study, 1963). No human evidence for A. menziesii.
In vitro antioxidant data for A. menziesii specifically are sparse. In a comparative phytochemical study of Arbutus species leaf infusions, A. menziesii exhibited the highest procyanidin concentration (6.48 Ā± 0.48 mg CE/g DW) among the species evaluated. This suggests A. menziesii may have a robust proanthocyanidin content contributing to antioxidant capacity, though no standardized DPPH or ORAC assay results have been published exclusively for A. menziesii in the peer-reviewed literature.
For the genus broadly, multiple DPPH radical-scavenging and other in vitro assays have confirmed antioxidant activity in leaf extracts. In an A. unedo study, total phenolic content was determined to be 197.16 Ā± 1.43 mg GAE/g extract in aqueous extract. These findings are genus-level evidence and cannot be directly extrapolated to A. menziesii preparations without species-specific data.
Evidence strength: Limited preliminary data (in vitro) for the species. Broader in vitro evidence exists for genus congeners. No human evidence.
The use of Pacific madrone bark and leaf preparations for digestive ailments is among the best-documented traditional applications. Leaves and bark were also used for medicinal properties such as cold remedy and stomach issues (Turner and Hebda 1990).
The high tannin content provides a plausible mechanism: astringent tannins precipitate mucosal proteins, reduce gut permeability, and may inhibit bacterial pathogens involved in diarrhea. Studies on related Arbutus unedo show spasmolytic properties in vitro; ethanol extracts from A. unedo (used traditionally for gastrointestinal complaints) were found to decrease ileal basal tonus. This is genus-level in vitro evidence.
Evidence strength: Traditional use is well-documented across multiple Indigenous traditions. Plausible mechanism from constituent tannins. No clinical trials for A. menziesii specifically.
Medicinally, Arbutus menziesii is used as an astringent, a tea for bladder infections, and as a sitz bath for other types of infections. The genus-level precedent for urinary antiseptic use in related Ericaceae members (particularly bearberry, Arctostaphylos uva-ursi, which contains arbutin as its primary active) is well established in European pharmacopeias, though not yet for A. menziesii specifically. Arbutin, present in Ericaceae broadly, hydrolyzes in the urinary tract to release hydroquinone, which has demonstrated antibacterial properties in alkaline urine.
Evidence strength: Traditional use documented. Plausible mechanism via arbutin/tannin chemistry. No clinical trials specific to A. menziesii.
Respiratory ailments were treated with bark of Arbutus menziesii (among other species) by Salishan peoples of Vancouver Island, as documented by Turner and Hebda (1990). Tribal healers prepared bark tea to treat stomach ailments, colds, tuberculosis, and various internal disorders.
No laboratory or clinical data have been published specifically assessing respiratory pharmacological effects of A. menziesii extracts.
Evidence strength: Historically and ethnobotanically well-documented traditional use. No pharmacological or clinical evidence.
The astringent properties of the inner bark made it valuable for treating wounds, sores, cuts, and diarrhea. Many Pacific Northwest tribes (including the Cowichan, Hoh, Saanich, Salish, and others) have used the leaves as a burn dressing.
Tannin-rich plant preparations have a well-established historical record in wound management. The protein-precipitating and antimicrobial properties of gallotannins and condensed tannins provide a mechanistic rationale. However, no controlled wound-healing clinical studies have been published for A. menziesii preparations.
Evidence strength: Traditional use well-documented. Plausible mechanism via tannin astringency. No clinical trials.
Gynaecological problems were treated with bark of Arbutus menziesii (among other plants) by Salishan women, as documented by Turner and Hebda in their 1990 ethnopharmacological study. The WSANEÄ peoples used the bark and leaves medicinally as a post-childbirth contraceptive.
No pharmacological studies have investigated the hormonal, uterotonic, or contraceptive properties of A. menziesii preparations.
Evidence strength: Documented exclusively through ethnobotanical records. No scientific evidence.
No formal dosage regimens have been established in clinical or pharmacological studies for Arbutus menziesii. The following preparation methods and use contexts are documented in ethnobotanical and historical sources only:
Note: No peer-reviewed study has defined a therapeutic dose, standardized extract specification, or pharmacokinetic data for any A. menziesii preparation.
Pacific madrone bark and leaves are rich in gallotannins and condensed tannins. High intake of tannin-rich preparations is associated with reduced iron absorption due to complex formation with dietary iron. Prolonged high-dose oral tannin consumption has been associated with gastrointestinal irritation in general phytomedicine contexts, though no specific safety data on A. menziesii bark tea doses have been published in the indexed literature.
Arbutin, a constituent present in the Ericaceae family broadly, is metabolized in the body to release hydroquinone. Because one of the potential products of its degradation is free hydroquinone, which raises some doubts concerning its toxicological safety, special attention is paid to the stability of Ī²-arbutin. It is known that up to 70% of arbutin can be converted to hydroquinone. However, due to extensive conjugation and rapid excretion, the amount of free hydroquinone in tissues and organs is usually less than 2% of the total administered dose.
In a preclinical toxicology study using Sprague-Dawley rats, Ī±-arbutin showed no remarkable toxicity at tested doses, with an LDā ā exceeding 2000 mg/kg. However, at higher doses, male rats exhibited elevated liver enzymes and chloride ions, along with brain inflammation and cortical necrosis.
For topical applications containing arbutin, the European Scientific Committee on Consumer Safety (SCCS) has assessed safety: aggregate exposure of alpha-arbutin (2% in face cream and 0.5% in body lotion) with beta-arbutin (7% in face cream) are considered safe. Hydroquinone should remain as low as possible in formulations containing alpha- or beta-arbutin and should not be higher than the unavoidable traces in both arbutins.
These safety assessments pertain to cosmetic arbutin, not to oral consumption of A. menziesii bark or leaf preparations. The direct applicability to ingested A. menziesii preparations has not been formally evaluated.
The fruit is edible, but due to its high tannin content, it is quite astringent. Flavor varies by site and season; many foragers harvest when berries are deep red in cool fall weather and process (cook/dry) to mellow tannins. Reports of narcotic properties probably relate only to natural fermentation in the pulp, rather than to some more specific drug.
In a 14-day and 28-day rat study using A. unedo water leaf extract, arbutin, and hydroquinone, findings suggest no significant changes in haematological parameters following prolonged exposure to strawberry tree water leaf extract, arbutin, and hydroquinone. All experimental animals survived the experiments and there were no signs of systemic toxicity following exposure to tested compounds. These results are from a related species and a controlled animal experiment and cannot be directly extrapolated to human oral use of A. menziesii preparations.
No formal acute or chronic toxicity studies, mutagenicity assessments, human safety trials, or drug interaction studies have been published specifically for Arbutus menziesii bark or leaf preparations intended for oral consumption as a supplement. The absence of published adverse event data should not be interpreted as evidence of safety; rather, it reflects the near-complete lack of formal pharmacological investigation.
Pacific madrone remains one of the most ethnobotanically rich yet scientifically under-investigated trees in North America. The major evidence gaps include:
There is little information about the biological activities and chemical composition of most species of Arbutus beyond A. unedo. This observation by researchers characterizing the genus applies with particular force to A. menziesii. The existing evidence base places Pacific madrone firmly in the category of a traditionally and ethnobotanically important plant with plausible bioactive chemistry, but with a scientific evidence base that remains at the earliest, most preliminary stage of modern phytomedicinal investigation.
Health conditions that Pacific madrone may help support.
Body systems that Pacific madrone may help support.
Go back